Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
SUBSTITUTED PIPERIDINE COMPOUND AS OREXIN TYPE 2 AGONIST FOR THE TREATMENT OF NARCOLEPSY
No-Receipt date
2024-03553 - 30/09/2024
No-Filing date
20240402263 - 30/09/2024
No-Granting date
3116491 - 14/10/2024
No-EPO application date
21209107.8 - 01/02/2017
No-EPO granting date
3984994 - 03/07/2024
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2024 - 11/11/2024
Expiration date
02/02/2037
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
JP201601983404/02/2016/JP
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/435
A61P 25/00
C07D 211/24
C07D 211/36
C07D 211/56
C07D 401/06
C07D 401/12
C07D 401/14
C07D 405/06
C07D 405/12
C07D 405/14
C07D 409/06
C07D 409/12
C07D 413/06
C07D 417/06
C07D 417/14
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1656751
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME CHUO-KU
OSAKA-SHI, OSAKA 541-0045
JAPAN
Inventors
Code
Firstname
Surname
4329151
FUJIMOTO, TATSUHIKO
4329152
RIKIMARU, KENTARO
4329153
FUKUDA, KOICHIRO
4329154
SUGIMOTO, HIROMICHI
4329155
MATSUMOTO, TAKAHIRO
4329156
TOKUNAGA, NORIHITO
4329157
HIROZANE, MARIKO
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
9 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).